QPS Holdings and Hepregen Corporation Announce Commercial Partnership

News   May 30, 2013

 
QPS Holdings and Hepregen Corporation Announce Commercial Partnership
 
 
 

RELATED ARTICLES

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

New Drug Class: Potential Therapeutics for Alzheimer’s Disease?

News

One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.

READ MORE

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE